Option Investor
Newsletter

ADDITIONAL RECOMMENDATIONS FOR OCTOBER - Option Writer 9-20-06

HAVING TROUBLE PRINTING?
Printer friendly version


We are recommending the following three put writes to our OCTOBER RECOMMENDED LIST.

We are recommending put writes on the following issues:


NRMX - Neurochem, Inc., a biopharmaceutical company, engages in the development and commercialization of therapeutics primarily for neurological diseases. Its products include Eprodisate (Fibrillex), a Phase II/III clinical trail completed product, which would be used for the treatment of amyloid a amyloidosis; Tramiprosate (Alzhemed), a Phase III clinical trial product, for the treatment of Alzheimer's disease; and Tramiprosate (Cerebril), a Phase IIa clinical trial completed product for the treatment of hemorrhagic stroke. Neurochem was founded in 1993 and is based in Laval, Canada.

GLBC - Global Crossing Limited provides telecommunications services, which include voice, data, and collaboration services worldwide. It offers switched outbound and inbound voice services for domestic and international long-distance traffic; toll-free enhanced routing services; and commercial managed voice services. The company's data services include network interconnectivity; capacity; and access services. These services comprise converged IP, IP VPN, VOIP, Ethernet IP, Internet access, frame relay and ATM, managed solutions, transport, and collocation services. Its collaboration services consist of audio, video, and Web conferencing services.

We are recommending the following specific put writes

NRMX 17.21
SELL OPEN OCT 15 PUT = KQM-VC
Target Price $35.00
Potential Profit(10 x = $350.00

Initial Margin $3,792 10 (contracts)
Return on Investment 9.23%
Cost Basis in Stock = $14.65
Days to Expiration = 30
Stock goes on Watch List Price at: $16.50
STOP EXIT STRATEGY
Close option position if Stock CLOSES less than $15.00


GLBC 18.98
SELL OPEN OCT 17.5 PUT =
GQC-VW
Target Price $30.00
Potential Profit(10 x = $300.00

Initial Margin $4,096 10 (contracts)
Return on Investment 7.32%
Cost Basis in Stock = $17.20
Days to Expiration = 30
Stock goes on Watch List Price at: $18.00
STOP EXIT STRATEGY
Close option position if Stock CLOSES less than $17.50

Option Writers Newsletter Archives